Brain volume loss and no evidence of disease activity over 3 years in multiple sclerosis patients under interferon beta 1a subcutaneous treatment

Authors:

Abstract
No abstract available
Funding Information
  • Merck KGaA

This publication has 24 references indexed in Scilit: